UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of clinical oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 26, pp. 3219 - 3225
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Stomach Neoplasms - pathology | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Young Adult | Peritoneal Neoplasms - drug therapy | Lung Neoplasms - secondary | Adult | Female | Liver Neoplasms - secondary | Peritoneal Neoplasms - secondary | Pyridines - therapeutic use | Double-Blind Method | Liver Neoplasms - drug therapy | Survival Rate | Stomach Neoplasms - drug therapy | Peritoneal Neoplasms - mortality | International Agencies | Adolescent | Aged | Neoplasm Staging | Stomach Neoplasms - mortality | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | General aspects | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Immunomodulators | Tumors | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Cell stem cell, ISSN 1934-5909, 2010, Volume 6, Issue 6, pp. 603 - 615
STEMCELL | CELLCYCLE | Cell & Tissue Engineering | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Fundamental and applied biological sciences. Psychology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Cell differentiation, maturation, development, hematopoiesis | Biological and medical sciences | Cell physiology | Molecular and cellular biology | Medical sciences | Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes | Tumors | Neoplasm Transplantation | RNA, Small Interfering - genetics | Prognosis | Follow-Up Studies | Apoptosis - drug effects | Neoplastic Stem Cells - drug effects | Colorectal Neoplasms - genetics | Humans | Apoptosis - genetics | Gene Expression Profiling | Colorectal Neoplasms - diagnosis | Organoplatinum Compounds - pharmacology | Neoplastic Stem Cells - metabolism | Cell Transformation, Neoplastic - genetics | Colorectal Neoplasms - drug therapy | Liver Neoplasms - physiopathology | Neoplastic Stem Cells - pathology | Tumor Burden - genetics | Tumor Cells, Cultured | Liver Neoplasms - secondary | Colorectal Neoplasms - metabolism | Carcinoma - secondary | Carcinoma - drug therapy | Liver Neoplasms - genetics | Dipeptidyl Peptidase 4 - biosynthesis | Liver Neoplasms - drug therapy | Carcinoma - diagnosis | Dipeptidyl Peptidase 4 - genetics | Mice, SCID | Carcinoma - physiopathology | Disease Progression | Colorectal Neoplasms - physiopathology | Drug Resistance, Neoplasm - genetics | Animals | Liver Neoplasms - diagnosis | Tumor Burden - drug effects | Liver Neoplasms - metabolism | Carcinoma - genetics | Biomarkers, Tumor - genetics | Fluorouracil - pharmacology | Mice | Carcinoma - metabolism | Colorectal Neoplasms - pathology | Neoplasm Invasiveness - genetics | Cell Migration Assays | Biomarkers, Tumor - biosynthesis | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 11/2007, Volume 25, Issue 33, pp. 5281 - 5286
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Uterine Cervical Neoplasms - radiotherapy | Humans | Head and Neck Neoplasms - drug therapy | Lung Neoplasms - radiotherapy | Neoplasms - mortality | Uterine Cervical Neoplasms - drug therapy | Antineoplastic Agents - therapeutic use | Esophageal Neoplasms - radiotherapy | Urinary Bladder Neoplasms - drug therapy | Neoplasms - drug therapy | Head and Neck Neoplasms - radiotherapy | Urinary Bladder Neoplasms - radiotherapy | Cisplatin - therapeutic use | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Female | Neoadjuvant Therapy | Neoplasms - radiotherapy | Carcinoma, Non-Small-Cell Lung - drug therapy | Chemotherapy, Adjuvant | Esophageal Neoplasms - drug therapy | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 34, pp. 4297 - 4305
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Colorectal Neoplasms - surgery | Multivariate Analysis | Sulfones - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Colectomy | Neoplasm Recurrence, Local - enzymology | Patient Selection | Neoplasm Recurrence, Local - pathology | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Aspirin - therapeutic use | Chemotherapy, Adjuvant | Colorectal Neoplasms - mortality | Colorectal Neoplasms - enzymology | Genetic Predisposition to Disease | Neoplasm Recurrence, Local - prevention & control | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Cyclooxygenase 2 - analysis | Lactones - therapeutic use | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Phenotype | Class I Phosphatidylinositol 3-Kinases | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Mutation | Colorectal Neoplasms - pathology | Index Medicus
Journal Article
Clinical & translational oncology, ISSN 1699-048X, 12/2019, Volume 21, Issue 12, pp. 1707 - 1711
Breakthrough pain | Oncology | Pelvic 3D radiotherapy | Medicine & Public Health | Proctalgia | Life Sciences & Biomedicine | Science & Technology | Endometrial Neoplasms - radiotherapy | Prostatic Neoplasms - radiotherapy | Prevalence | Pain - epidemiology | Humans | Middle Aged | Breakthrough Pain - epidemiology | Male | Breakthrough Pain - drug therapy | Pain - drug therapy | Aged, 80 and over | Adult | Female | Neoplasms - radiotherapy | Rectal Neoplasms - drug therapy | Breakthrough Pain - etiology | Prostatic Neoplasms - drug therapy | Radiotherapy Dosage | Cancer Pain - epidemiology | Uterine Cervical Neoplasms - radiotherapy | Cross-Sectional Studies | Rectal Diseases - drug therapy | Urinary Bladder Neoplasms - drug therapy | Chi-Square Distribution | Rectal Neoplasms - radiotherapy | Neoplasms - drug therapy | Cancer Pain - drug therapy | Urinary Bladder Neoplasms - radiotherapy | Anus Neoplasms - drug therapy | Spain - epidemiology | Anus Neoplasms - radiotherapy | Cancer Pain - etiology | Rectal Diseases - epidemiology | Radiotherapy, Conformal - adverse effects | Aged | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 06/2012, Volume 486, Issue 7404, pp. 532 - 536
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Immunotherapy | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | ErbB Receptors - antagonists & inhibitors | Antibodies, Monoclonal - pharmacology | Colorectal Neoplasms - genetics | Humans | Panitumumab | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Antibodies, Monoclonal - therapeutic use | Proto-Oncogene Proteins - genetics | Mutation - genetics | Promoter Regions, Genetic - genetics | Disease Progression | Antibodies, Monoclonal, Humanized | Drug Resistance, Neoplasm - genetics | Colorectal Neoplasms - drug therapy | Alleles | Cell Line, Tumor | Cetuximab | Colorectal Neoplasms - pathology | Drug Resistance, Neoplasm - drug effects | Genes, ras - genetics | Proteins | Cloning | Mutation | Kinases | Experiments | Cancer therapies | Mass spectrometry | Index Medicus | targeted therapy | KRAS | colorectal cancer | acquired resistance
Journal Article
Annals of oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue 9, pp. 2313 - 2318
clinical trial | phase II | cetuximab | colorectal neoplasms | retreatment | Retreatment | Clinical trial | Phase II | Colorectal neoplasms | Cetuximab | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Liver Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Antibodies, Monoclonal, Humanized | Lung Neoplasms - secondary | Exanthema - chemically induced | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Treatment Outcome | Lymphatic Metastasis | Disease-Free Survival | Irinotecan | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 04/2014, Volume 20, Issue 7, pp. 1891 - 1899
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Radiotherapy Dosage | Neoplasm Recurrence, Local - radiotherapy | Prognosis | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Lymphatic Metastasis - immunology | Male | Treatment Outcome | Combined Modality Therapy | Rectal Neoplasms - radiotherapy | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Biopsy | Lymphatic Metastasis - pathology | CD3 Complex - immunology | Aged, 80 and over | Female | Aged | Rectal Neoplasms - pathology | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Rectal Neoplasms - drug therapy | Rectal Neoplasms - immunology | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 10/2014, Volume 25, Issue 10, pp. 1995 - 2001
oncogenic pathways | mutations | colon cancer | expression profiling | survival | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Colonic Neoplasms - genetics | Microsatellite Instability | Prognosis | Neoplasm Proteins - biosynthesis | Colonic Neoplasms - drug therapy | Humans | Translational Medical Research | Neoplasm Recurrence, Local - drug therapy | Male | DNA Copy Number Variations - genetics | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Neoplasm Metastasis | Colonic Neoplasms - pathology | Female | Neoplasm Recurrence, Local - genetics | Neoplasm Proteins - genetics | Neoplasm Staging | Gene Expression Regulation, Neoplastic - genetics | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 09/2011, Volume 22, Issue 9, pp. 2042 - 2048
bevacizumab | capecitabine | oxaliplatin | colorectal cancer | liver metastases | Liver metastases | Oxaliplatin | Capecitabine | Colorectal cancer | Bevacizumab | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Colorectal Neoplasms - surgery | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Colorectal Neoplasms - therapy | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Colorectal Neoplasms - drug therapy | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Risk Factors | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Adenocarcinoma - therapy | Perioperative Care - methods | Aged | Colorectal Neoplasms - pathology | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Adenocarcinoma - surgery | Index Medicus
Journal Article